New York, NY·Biotechnology, Investment Management, Healthcare·Last fund filed December 2017
Funds on file
1
Partners named
14
14 on a current fund
Recent board seats
5
last 24 months
Capital raised
$26M
across filed funds
What has Vestar Executives raised?
1 vehicle
Vehicle
Filed
Target
Sold to date
Investors
VESTAR EXECUTIVES VII, L.P.
December 2017
$50M
$26M
70
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
Who at Vestar Executives can lead a round?
14 named
14 partners are named across this firm’s filings, 14 of them on a fund it is deploying now.
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Healthcare services2 · 9%
Robotics & hardware2 · 9%
E-commerce & marketplaces1 · 5%
HR & future of work1 · 5%
Legal & compliance tech1 · 5%
Sales & marketing tech1 · 5%
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Vestar Executives’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
A shared board seat: a company where filings name a Vestar Executives partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
